Since we have demonstrated the significant effect of PVC in kinetic parameter estimation, future dynamic PET studies focusing on other PET-tracers in small tumors (e.g., PSMA-ligand tracers in prostate cancer metastases) should apply PVC as a similar (or larger) impact of PVC may be expected. This evidence concerns the gene FOLH1 and prostate carcinoma.